Cefixime NDC 70518-3221

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3221Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3221Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3221-2	70518322102	2 POUCH in 1 BOX (70518-3221-2) / 1 CAPSULE in 1 POUCH (70518-3221-3)Marketed from Nov 4, 2021
70518-3221-4	70518322104	2 CAPSULE in 1 BOTTLE, PLASTIC (70518-3221-4)Marketed from Mar 2, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefixime
Generic name (nonproprietary): cefixime
Active ingredients: Cefixime — 400 mg/1
Dosage form: Capsule
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 203195
Marketing start: Sep 14, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 70518-3221_584f16e8-696b-ed5a-e063-6294a90a7ef0SPL ID 584f16e8-696b-ed5a-e063-6294a90a7ef0SPL set ID 3194433c-c04e-442b-9668-fbeb0a15bac7RxCUI 409823UNII 97I1C92E55
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518322102 followed by a unit qualifier and the quantity

Package 70518-3221-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2026.

Indications (excerpt from the label)

Cefixime is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections ( 1.1 ) Otitis Media ( 1.2 ) Pharyngitis and Tonsillitis ( 1.3 ) Acute Exacerbations of Chronic Bronchitis ( 1.4 ) Uncomplicated Gonorrhea (cervical/urethral) ( 1.5 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime and other antibacterial drugs, cefixime for oral suspension and cefixime capsules should be used only to treat infections that are proven or strongly suspected to be caused by bacteria…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 203195

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 203195
Product	Strength	Form · route	Labeler	Product NDC
Cefixime	Cefixime 400 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-423